Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease

Table 1 Serum Ang II expression in each group (mean ± SD)

Groups	6th week	10th week	14th week
Normal	390.68 ± 15.34	424.54 ± 7.66	475.78 ± 10.51
Model	929.61 ± 463.21a,b,c	1244.61 ± 232.81a,c	1567.04 ± 273.22a,d
Intervention			1349.04 ± 433.22a

^aP < 0.01 vs the control group;

^bP < 0.05 vs the model group in the 10^th week;

^cP < 0.05 vs the model group in the 14^th week;

^dP < 0.05 vs the intervention group in the 14^th week.

Table 2 Nuclear factor-κB protein expression in rat hepatocytes from each group (mean ± SD, n = 6)

Groups	6th week	10th week	14th week
Normal	4.48 ± 0.34	4.26 ± 0.66	4.78 ± 0.74
Model	29.61 ± 3.21a,b,c	44.61 ± 2.81a,c	67.04 ± 3.22a,d
Intervention			49.04 ± 3.22a

^aP < 0.01 vs the control group;

^bP < 0.05 vs the model group in the 10^th week;

^cP < 0.05 vs the model group in the 14^th week;

^dP < 0.05 vs the intervention group in the 14^th week.